These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 38340254)

  • 1. Effect of gut microbiota-derived metabolites and extracellular vesicles on neurodegenerative disease in a gut-brain axis chip.
    Kim NY; Lee HY; Choi YY; Mo SJ; Jeon S; Ha JH; Park SD; Shim JJ; Lee J; Chung BG
    Nano Converg; 2024 Feb; 11(1):7. PubMed ID: 38340254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ-On-A-Chip
    Raimondi I; Izzo L; Tunesi M; Comar M; Albani D; Giordano C
    Front Bioeng Biotechnol; 2019; 7():435. PubMed ID: 31998702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of the Gut Microbiota and Microbial Metabolites in the Pathogenesis of Alzheimer's Disease.
    Wang Y
    CNS Neurol Disord Drug Targets; 2023; 22(4):577-598. PubMed ID: 35440320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut-Brain Axis and its Neuro-Psychiatric Effects: A Narrative Review.
    Shaik L; Kashyap R; Thotamgari SR; Singh R; Khanna S
    Cureus; 2020 Oct; 12(10):e11131. PubMed ID: 33240722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the gut microbiome in neurodegenerative diseases and metagenomic approaches for characterization of gut microbes.
    Singh N; Singh V; Rai SN; Mishra V; Vamanu E; Singh MP
    Biomed Pharmacother; 2022 Dec; 156():113958. PubMed ID: 36411639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of gut microbiome-derived metabolites and extracellular vesicles on hepatocyte functions in a gut-liver axis chip.
    Kang SG; Choi YY; Mo SJ; Kim TH; Ha JH; Hong DK; Lee H; Park SD; Shim JJ; Lee JL; Chung BG
    Nano Converg; 2023 Jan; 10(1):5. PubMed ID: 36645561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia.
    Connell E; Le Gall G; Pontifex MG; Sami S; Cryan JF; Clarke G; Müller M; Vauzour D
    Mol Neurodegener; 2022 Jun; 17(1):43. PubMed ID: 35715821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gut-immune-brain axis in neurodevelopment and neurological disorders.
    Park JC; Im SH
    Microbiome Res Rep; 2022; 1(4):23. PubMed ID: 38046904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Microbiome-Brain Communication on Neuroinflammation and Neurodegeneration.
    Stolzer I; Scherer E; Süß P; Rothhammer V; Winner B; Neurath MF; Günther C
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota-derived short chain fatty acids act as mediators of the gut-brain axis targeting age-related neurodegenerative disorders: a narrative review.
    Guo B; Zhang J; Zhang W; Chen F; Liu B
    Crit Rev Food Sci Nutr; 2023 Oct; ():1-22. PubMed ID: 37897083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Getting closer to modeling the gut-brain axis using induced pluripotent stem cells.
    Hall V; Bendtsen KMS
    Front Cell Dev Biol; 2023; 11():1146062. PubMed ID: 37065853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders.
    Zheng Y; Bonfili L; Wei T; Eleuteri AM
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Microbiota-Gut-Brain Axis.
    Cryan JF; O'Riordan KJ; Cowan CSM; Sandhu KV; Bastiaanssen TFS; Boehme M; Codagnone MG; Cussotto S; Fulling C; Golubeva AV; Guzzetta KE; Jaggar M; Long-Smith CM; Lyte JM; Martin JA; Molinero-Perez A; Moloney G; Morelli E; Morillas E; O'Connor R; Cruz-Pereira JS; Peterson VL; Rea K; Ritz NL; Sherwin E; Spichak S; Teichman EM; van de Wouw M; Ventura-Silva AP; Wallace-Fitzsimons SE; Hyland N; Clarke G; Dinan TG
    Physiol Rev; 2019 Oct; 99(4):1877-2013. PubMed ID: 31460832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut-Brain Axis a Key Player to Control Gut Dysbiosis in Neurological Diseases.
    Pan I; Issac PK; Rahman MM; Guru A; Arockiaraj J
    Mol Neurobiol; 2023 Oct; ():. PubMed ID: 37851313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional roles of the microbiota-gut-brain axis in Alzheimer's disease: Implications of gut microbiota-targeted therapy.
    Zhong SR; Kuang Q; Zhang F; Chen B; Zhong ZG
    Transl Neurosci; 2021 Jan; 12(1):581-600. PubMed ID: 35070442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Gut-Microbiota Interaction in Neurodegenerative Disorders and Current Engineered Tools for Its Modeling.
    Ceppa FA; Izzo L; Sardelli L; Raimondi I; Tunesi M; Albani D; Giordano C
    Front Cell Infect Microbiol; 2020; 10():297. PubMed ID: 32733812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota-Host Immunity Communication in Neurodegenerative Disorders: Bioengineering Challenges for In Vitro Modeling.
    Boeri L; Perottoni S; Izzo L; Giordano C; Albani D
    Adv Healthc Mater; 2021 Apr; 10(7):e2002043. PubMed ID: 33661580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiota-derived metabolites as drivers of gut-brain communication.
    Ahmed H; Leyrolle Q; Koistinen V; Kärkkäinen O; Layé S; Delzenne N; Hanhineva K
    Gut Microbes; 2022; 14(1):2102878. PubMed ID: 35903003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut-brain Axis: Role of Lipids in the Regulation of Inflammation, Pain and CNS Diseases.
    Russo R; Cristiano C; Avagliano C; De Caro C; La Rana G; Raso GM; Canani RB; Meli R; Calignano A
    Curr Med Chem; 2018; 25(32):3930-3952. PubMed ID: 28215162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
    Albillos A; de Gottardi A; Rescigno M
    J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.